Atrial natriuretic factor (1-28) (human, porcine) TFA

(Synonyms: Atrial natriuretic peptide (1-28) TFA)
1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

Atrial natriuretic factor (1-28) (human, porcine) TFA exhibits blood pressure lowering activity by increasing sodium and urine excretion. Atrial natriuretic factor (1-28) (human, porcine) TFA inhibits the release of pituitary adrenocorticotropic hormone (ACTH) and beta-endorphin through inhibition of pro-opiomelanocortin (POMC) expression. Atrial natriuretic factor (1-28) (human, porcine) TFA increases cGMP levels in RMIC cells with an IC50 of 1.2 nM.

For research use only. We do not sell to patients.

  • Purity : 98.23%
  • Formula: C127H205N45O39S3.xC2HF3O2
  • Molecular Weight:3080.46 (free base)
  • Storage:

    Sealed storage, away from moisture.

    Powder   -80°C, 2 years , -20°C, 1 year

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Atrial natriuretic factor (1-28) (human, porcine) TFA

More

All Endogenous Metabolite Isoforms

More
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00